Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum ; volume:146 ; number:3 ; day:19 ; month:7 ; year:2023 ; pages:433-450 ; date:9.2023
Acta neuropathologica ; 146, Heft 3 (19.7.2023), 433-450, 9.2023
- Urheber
-
Gittings, Lauren M.
Alsop, Eric B.
Antone, Jerry
Singer, Mo
Whitsett, Timothy G.
Sattler, Rita
Keuren-Jensen, Kendall Van
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-023-02599-5
- URN
-
urn:nbn:de:101:1-2023110209115154689301
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gittings, Lauren M.
- Alsop, Eric B.
- Antone, Jerry
- Singer, Mo
- Whitsett, Timothy G.
- Sattler, Rita
- Keuren-Jensen, Kendall Van
- SpringerLink (Online service)
Ähnliche Objekte (12)
The era of cryptic exons: implications for ALS-FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes
The era of cryptic exons: implications for ALS-FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
The ALS/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes
The era of cryptic exons: implications for ALS-FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA